Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled, Double-blind, Parallel Study to Determine the Effect of Farlong® NotoGinseng™ (Farlong® Ginseng Plus®) on Cholesterol and Blood Pressure

NCT04069715 is registered in ClinicalTrials.gov with LongStar HealthPro, Inc. DBA Farlong Pharmaceutical as lead sponsor.

NCT NCT04069715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04069715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled, Double-blind, Parallel Study to Determine the Effect of Farlong® NotoGinseng™ (Farlong® Ginseng Plus®) on Cholesterol and Blood Pressure
Lead sponsor
LongStar HealthPro, Inc. DBA Farlong Pharmaceutical
Phase
Phase 2
Overall status
Completed
Start date
July 20, 2016
Completion date
June 1, 2019
Enrollment
95 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemias, hypertension